Intensity-modulated radiation therapy as primary treatment for oropharyngeal squamous cell carcinoma

Head and Neck

Volumn 35, Issue 12, 2013, Pages 1796-1800

  May, James T ^a   Rao, Nikhil ^a   Sabater, Roberto D ^a   Boutrid, Hinda ^a   Caudell, Jimmy J ^a   Merchant, Faisal ^a   Han, Gang ^a   Padhya, Tapan A ^a   McCaffrey, Judith C ^a   Tanvetyanon, Tawee ^a   Deconti, Ronald ^a   Kish, Julie ^a   McCaffrey, Thomas V ^a   Trotti, Andy ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

disease control; head and neck cancer; intensity modulated radiation therapy; oropharyngeal carcinoma; treatment toxicity

Indexed keywords

CARBOPLATIN; CETUXIMAB; CISPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE CYCLE TREATMENT; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION INJURY; SQUAMOUS CELL CARCINOMA;

DISEASE CONTROL; HEAD AND NECK CANCER; INTENSITY-MODULATED RADIATION THERAPY; OROPHARYNGEAL CARCINOMA; TREATMENT TOXICITY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DISEASE-FREE SURVIVAL; ENTERAL NUTRITION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES;

EID: 84887994063     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23245     Document Type: Article

References (28)

1. Vikram B,. Changing patterns of failure in advanced head and neck cancer. Arch Otolaryngol 1984; 110: 564-565.
2. Mendenhall WM, Morris CG, Amdur RJ, Hinerman RW, Werning JW, Villaret DB,. Definitive radiotherapy for squamous cell carcinoma of the base of tongue. Am J Clin Oncol 2006; 29: 32-39.
3. Mendenhall WM, Morris CG, Amdur RJ, et al. Definitive radiotherapy for tonsillar squamous cell carcinoma. Am J Clin Oncol 2006; 29: 290-297.
4. Chao KS, Deasy JO, Markman J, et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 2001; 49: 907-916.
5. Eisbruch A, Kim HM, Terrell JE, Marsh LH, Dawson LA, Ship JA,. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001; 50: 695-704.
6. Greene FL, Page DL, Fleming ID, et al., editors. AJCC Cancer Staging Manual, 6th edition). New York: Springer-Verlag; 2002.
7. Common Toxicity Criteria Version 2.0. http://ctep.cancer.gov/ protocolDevelopment/electronic-applications/docs/ctcv20-4-30-992.pdf. Accessed September 15, 2011.
8. RTOG/EORTC Late Radiation Morbidity Scoring Schema. http://www.rtog.org/ ResearchAssociates/AdverseEventReporting/ RTOGEORTCLateRadiationMorbidityScoringSchema.aspx. Accessed September 15, 2011.
9. Rusthoven KE, Raben D, Ballonoff A, Kane M, Song JI, Chen C,. Effect of radiation techniques in treatment of oropharynx cancer. Laryngoscope 2008; 118: 635-639.
10. Lee NY, de Arruda FF, Puri DR, et al. A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2006; 66: 966-974.
11. Daly ME, Le QT, Maxim PG, et al. Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: clinical outcomes and patterns of failure. Int J Radiat Oncol Biol Phys 2010; 76: 1339-1346.
12. Garden AS, Morrison WH, Wong PF, et al. Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2007; 67: 438-444.
13. Huang K, Xia P, Chuang C, et al. Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma. Cancer 2008; 113: 497-507.
14. Sanguineti G, Gunn GB, Endres EJ, Chaljub G, Cheruvu P, Parker B,. Patterns of locoregional failure after exclusive IMRT for oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2008; 72: 737-746.
15. Shoushtari A, Meeneghan M, Sheng K, et al. Intensity-modulated radiotherapy outcomes for oropharyngeal squamous cell carcinoma patients stratified by p16 status. Cancer 2010; 116: 2645-2654.
16. Setton J, Caria N, Romanyshyn J, et al. Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 2012; 82: 291-298.
17. Feng FY, Kim HM, Lyden TH, et al. Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. J Clin Oncol 2010; 28: 2732-2738.
18. Saba NF, Edelman S, Tighiouart M, et al. Concurrent chemotherapy with intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the larynx and oropharynx: a retrospective single-institution analysis. Head Neck 2009; 31: 1447-1455.
19. Yao M, Nguyen T, Buatti JM, et al. Changing failure patterns in oropharyngeal squamous cell carcinoma treated with intensity modulated radiotherapy and implications for future research. Am J Clin Oncol 2006; 29: 606-612.
20. Mendenhall WM, Amdur RJ, Morris CG, Kirwan JM, Li JG,. Intensity-modulated radiotherapy for oropharyngeal squamous cell carcinoma. Laryngoscope 2010; 120: 2218-2222.
21. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML,. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008; 26: 612-619.
22. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
23. Nichols AC, Faquin WC, Westra WH, et al. HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg 2009; 140: 228-234.
24. Ragin CC, Taioli E,. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 2007; 121: 1813-1820.
25. Harrison LB, Zelefsky MJ, Pfister DG, et al. Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue. Head Neck 1997; 19: 169-175.
26. Jensen AB, Hansen O, Jorgensen K, Bastholt L,. Influence of late side-effects upon daily life after radiotherapy for laryngeal and pharyngeal cancer. Acta Oncol 1994; 33: 487-491.
27. Bjordal K, Kaasa S, Mastekaasa A,. Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy. Int J Radiat Oncol Biol Phys 1994; 28: 847-856.
28. Nutting CM, Morden JP, Harrington KJ, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011; 12: 127-136.